Overview |
bs-5344R-PE-Cy5.5 |
ECT2 (Thr373) Polyclonal Antibody, PE-Cy5.5 Conjugated |
WB |
Human, Dog, Cow, Sheep |
Specifications |
PE-Cy5.5 |
Rabbit |
KLH conjugated synthetic phosphopeptide derived from human ECT2 around the phosphorylation site of Thr373 |
Thr373 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
1894 |
Cytoplasm, Nucleus |
ECT2 phospho T373; ECT2 phospho Thr373; p-ECT2 Thr373; ECT 2; ECT2; ECT-2; ECT2 protein; Epithelial cell transforming sequence 2; Epithelial cell transforming sequence 2 oncogene; Epithelial cell transforming sequence 2 oncogene protein; FLJ10461; MGC138291; Protein ECT2; ECT2_HUMAN; Epithelial cell-transforming sequence 2 oncogene. |
The protein encoded by this gene is a transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of this gene is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis. [provided by RefSeq]. |
Application Dilution |
WB |
1:300-5000 |